US4242513A
(en)
|
1979-03-05 |
1980-12-30 |
Appleton Papers Inc. |
Lactone compounds containing a heterocyclic radical
|
WO1986007059A2
(fr)
|
1985-05-25 |
1986-12-04 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Composes d'oxodiazine
|
AU6355190A
(en)
|
1989-06-13 |
1991-01-17 |
Smithkline Beecham Corporation |
Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
|
AU5921890A
(en)
|
1989-06-13 |
1991-01-08 |
Smithkline Beecham Corporation |
Monokine activity interference
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
KR910011852A
(ko)
|
1989-12-04 |
1991-08-07 |
폴 디. 매튜카이티스 |
신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물
|
EP0533837A4
(en)
|
1990-06-12 |
1994-11-17 |
Smithkline Beecham Corp |
Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
|
US5137876A
(en)
|
1990-10-12 |
1992-08-11 |
Merck & Co., Inc. |
Nucleoside antiviral and anti-inflammatory compounds and compositions and methods for using same
|
AU9137591A
(en)
|
1990-12-13 |
1992-07-08 |
Smithkline Beecham Corporation |
Novel csaids
|
WO1992010498A1
(fr)
|
1990-12-13 |
1992-06-25 |
Smithkline Beecham Corporation |
Nouveaux medicaments anti-inflammatoires suppresseurs de cytokine
|
CN1033327C
(zh)
|
1991-04-23 |
1996-11-20 |
东丽株式会社 |
三环三唑并衍生物的制造方法
|
US5683998A
(en)
|
1991-04-23 |
1997-11-04 |
Toray Industries, Inc. |
Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
|
JPH06247969A
(ja)
|
1992-12-28 |
1994-09-06 |
Takeda Chem Ind Ltd |
縮合複素環化合物及びそれを含む農園芸用殺虫剤
|
DK31093D0
(fr)
|
1993-03-19 |
1993-03-19 |
Novo Nordisk As |
|
US5486525A
(en)
|
1993-12-16 |
1996-01-23 |
Abbott Laboratories |
Platelet activating factor antagonists: imidazopyridine indoles
|
US5869486A
(en)
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
AU5348396A
(en)
|
1995-05-01 |
1996-11-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivati ves and their use as bone resorption inhibitors
|
US6992188B1
(en)
|
1995-12-08 |
2006-01-31 |
Pfizer, Inc. |
Substituted heterocyclic derivatives
|
US20010007867A1
(en)
|
1999-12-13 |
2001-07-12 |
Yuhpyng L. Chen |
Substituted 6,5-hetero-bicyclic derivatives
|
EP0970082A2
(fr)
|
1997-02-18 |
2000-01-12 |
Neurocrine Biosciences, Inc. |
Antagonistes crf biazacycliques
|
US6054587A
(en)
|
1997-03-07 |
2000-04-25 |
Metabasis Therapeutics, Inc. |
Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
AU9041198A
(en)
|
1997-09-02 |
1999-03-22 |
Du Pont Pharmaceuticals Company |
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
|
US6248755B1
(en)
|
1999-04-06 |
2001-06-19 |
Merck & Co., Inc. |
Pyrrolidine modulators of chemokine receptor activity
|
JP4032566B2
(ja)
|
1999-06-21 |
2008-01-16 |
東レ株式会社 |
発光素子
|
JP2001057292A
(ja)
|
1999-08-20 |
2001-02-27 |
Toray Ind Inc |
発光素子
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
IL139197A0
(en)
|
1999-10-29 |
2001-11-25 |
Pfizer Prod Inc |
Use of corticotropin releasing factor antagonists and related compositions
|
EP1293213A1
(fr)
|
2000-02-14 |
2003-03-19 |
Japan Tobacco Inc. |
Agents prophylactiques/therapeutiques contre le stress postoperatoire
|
EP1149583A3
(fr)
|
2000-04-13 |
2001-11-14 |
Pfizer Products Inc. |
Combinaison des antagonistes de la facteur de la liberation de la corticotropin et des secrétagogues de l hormone de croissance
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
HUP0301801A2
(hu)
|
2000-07-14 |
2003-09-29 |
Bristol-Myers Squibb Pharma Company |
Imidazo[1,2-a]pirazin-származékok és az ezeket tartalmazó gyógyszerkészítmények
|
AU2001295992A1
(en)
|
2000-10-24 |
2002-05-06 |
Sankyo Company Limited |
Imidazopyridine derivatives
|
AU2002224927A1
(en)
|
2000-12-13 |
2002-06-24 |
Basf Aktiengesellschaft |
Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
|
AU2002243791B2
(en)
|
2001-01-22 |
2006-06-29 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
TWI312347B
(en)
|
2001-02-08 |
2009-07-21 |
Eisai R&D Man Co Ltd |
Bicyclic nitrogen-containing condensed ring compounds
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
KR20030076688A
(ko)
|
2001-02-20 |
2003-09-26 |
아스트라제네카 아베 |
Gsk3-관련 장애의 치료를 위한 2-아릴아미노-피리미딘
|
SE0100568D0
(sv)
|
2001-02-20 |
2001-02-20 |
Astrazeneca Ab |
Compounds
|
MXPA03007779A
(es)
|
2001-03-14 |
2004-11-12 |
Lilly Co Eli |
Moduladores de los receptores de retinoides x.
|
US20030032579A1
(en)
*
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
EP1382603B1
(fr)
|
2001-04-26 |
2008-07-23 |
Eisai R&D Management Co., Ltd. |
Compose azote a anneaux condenses possedant un groupe pyrazolyle et servant de substituant, et composition medicale le comprenant
|
US20030027820A1
(en)
|
2001-05-30 |
2003-02-06 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications V
|
US6806268B2
(en)
|
2001-05-30 |
2004-10-19 |
Alteon, Inc. |
Method for treating glaucoma V
|
ATE337316T1
(de)
|
2001-06-21 |
2006-09-15 |
Smithkline Beecham Corp |
Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
|
US7196095B2
(en)
|
2001-06-25 |
2007-03-27 |
Merck & Co., Inc. |
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
|
IL159811A0
(en)
|
2001-07-13 |
2004-06-20 |
Neurogen Corp |
Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
|
DE60211539T2
(de)
|
2001-10-05 |
2006-09-21 |
Smithkline Beecham Corp. |
Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
|
CA2472682A1
(fr)
|
2002-01-22 |
2003-07-31 |
Merck & Co., Inc. |
Traitement de la reaction de stress avec des modulateurs ccr5 du recepteur de chimiokine
|
JP4414232B2
(ja)
|
2002-03-05 |
2010-02-10 |
イーライ リリー アンド カンパニー |
キナーゼ阻害物質
|
JP2003313126A
(ja)
|
2002-04-23 |
2003-11-06 |
Sankyo Co Ltd |
イミダゾピリジン誘導体を有効成分とする医薬
|
JP2004002826A
(ja)
|
2002-04-24 |
2004-01-08 |
Sankyo Co Ltd |
高分子イミダゾピリジン誘導体
|
EP1505979A4
(fr)
|
2002-05-13 |
2006-08-30 |
Merck & Co Inc |
Imidazopyridines phenyle substituees et benzimidazoles phenyle substitues
|
US20040014957A1
(en)
|
2002-05-24 |
2004-01-22 |
Anne Eldrup |
Oligonucleotides having modified nucleoside units
|
TW200417547A
(en)
|
2002-07-31 |
2004-09-16 |
Smithkline Beecham Corp |
Compounds
|
GB0217783D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Compounds
|
ES2274302T3
(es)
|
2002-08-09 |
2007-05-16 |
Eli Lilly And Company |
Benzimidazoles y benzotiazoles como inhibidores de la map quinasa.
|
WO2004017950A2
(fr)
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Inhibiteurs de phosphatidylinositol 3,5-biphosphate en tant qu'agents antiviraux
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
US7312341B2
(en)
|
2002-09-09 |
2007-12-25 |
Cgi Pharmaceuticals, Inc. |
6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
|
EP1539749A4
(fr)
|
2002-09-13 |
2007-06-13 |
Merck & Co Inc |
Modulateurs du recepteur glutamate metabotropique 5 (mglur5) de phenyle substitues par un fragment heterobicyclo fusionne
|
EP1539756B1
(fr)
|
2002-09-19 |
2007-11-14 |
Schering Corporation |
Imidazopyridines utilisees comme inhibiteurs des kinases dependantes des cyclines
|
NZ563374A
(en)
|
2002-09-23 |
2009-06-26 |
Schering Corp |
Imidazopyrazines as cyclin dependent kinase inhibitors
|
NZ538686A
(en)
|
2002-09-23 |
2008-01-31 |
Schering Corp |
Novel imidazopyrazines as cyclin dependent kinase inhibitors
|
US7576085B2
(en)
|
2002-09-23 |
2009-08-18 |
Schering Corporation |
Imidazopyrazines as cyclin dependent kinase inhibitors
|
AU2003271185A1
(en)
|
2002-10-15 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Imidazopyridine derivative, process for producing the same, and use
|
US20060128695A1
(en)
*
|
2002-10-30 |
2006-06-15 |
Neuro3D |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
|
DK1576138T3
(en)
|
2002-11-15 |
2017-05-01 |
Idenix Pharmaceuticals Llc |
2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
|
CA2507026A1
(fr)
|
2002-11-22 |
2004-06-10 |
Takeda Pharmaceutical Company Limited |
Derives d'imidazole, leur procede de production et d'utilisation
|
WO2004063159A1
(fr)
|
2003-01-10 |
2004-07-29 |
Idemitsu Kosan Co., Ltd. |
Derive heterocyclique azote et element electroluminescent organique utilisant ce derive
|
WO2004072080A1
(fr)
|
2003-02-10 |
2004-08-26 |
Cellular Genomics, Inc. |
8-heteroaryle-6-phenyle-imidazo[1,2-a]pyrazines comme modulateurs de l'activite du complexe hsp90
|
US7186832B2
(en)
|
2003-02-20 |
2007-03-06 |
Sugen Inc. |
Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
|
US7329668B2
(en)
|
2003-02-25 |
2008-02-12 |
Bristol-Myers Squibb Company |
Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
|
PA8595001A1
(es)
|
2003-03-04 |
2004-09-28 |
Pfizer Prod Inc |
Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
|
US7041671B2
(en)
|
2003-04-02 |
2006-05-09 |
Pfizer Inc |
Pyrrolo[1,2-b]pyridazine compounds and their uses
|
JP2006522750A
(ja)
|
2003-04-11 |
2006-10-05 |
ノボ ノルディスク アクティーゼルスカブ |
代謝性症候群ならびに関連の疾患および障害を治療するために、11β−ヒドロキシステロイドデヒドロゲナーゼ1型阻害剤および抗高血圧剤を使用する併用療法
|
US20060094699A1
(en)
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
US20060100235A1
(en)
|
2003-04-11 |
2006-05-11 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
WO2004103991A1
(fr)
|
2003-05-20 |
2004-12-02 |
'chemical Diversity Research Institute', Ltd. |
Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique
|
WO2005020885A2
(fr)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions et methodes pour le traitement du syndrome respiratoire aigu severe (sras)
|
EP1630152A4
(fr)
|
2003-05-30 |
2009-09-23 |
Takeda Pharmaceutical |
Compose cyclique condense
|
US7405295B2
(en)
|
2003-06-04 |
2008-07-29 |
Cgi Pharmaceuticals, Inc. |
Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
|
US7393848B2
(en)
|
2003-06-30 |
2008-07-01 |
Cgi Pharmaceuticals, Inc. |
Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
|
AR045697A1
(es)
|
2003-07-14 |
2005-11-09 |
Arena Pharm Inc |
Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
|
US7259164B2
(en)
|
2003-08-11 |
2007-08-21 |
Cgi Pharmaceuticals, Inc. |
Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
|
KR100553752B1
(ko)
|
2003-10-13 |
2006-02-20 |
삼성에스디아이 주식회사 |
이미다졸 고리 함유 화합물 및 이를 이용한 유기 전계발광 소자
|
JP2007509960A
(ja)
|
2003-10-28 |
2007-04-19 |
セプラコア インコーポレーテッド |
イミダゾ[1,2−a]ピリジン抗不安薬
|
US20050288295A1
(en)
|
2003-11-11 |
2005-12-29 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
|
US20090023737A1
(en)
|
2004-02-12 |
2009-01-22 |
Neurogen Corporation |
Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
JP2005343889A
(ja)
|
2004-05-06 |
2005-12-15 |
Taisho Pharmaceut Co Ltd |
イミダゾピリジン誘導体
|
DE602005013085D1
(de)
|
2004-06-09 |
2009-04-16 |
Oncalis Ag |
Proteinkinaseinhibitoren
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
WO2006025567A1
(fr)
|
2004-08-31 |
2006-03-09 |
Banyu Pharmaceutical Co., Ltd. |
Nouveaux dérivés d’imidazoles substitués
|
EP1804801A2
(fr)
|
2004-10-15 |
2007-07-11 |
Biogen Idec MA, Inc. |
Procede pour traiter des lesions vasculaires
|
WO2006050351A2
(fr)
|
2004-10-28 |
2006-05-11 |
Irm Llc |
Composes et compositions servant de modulateurs de la voie de signalisation hedgehog
|
JP4935357B2
(ja)
|
2004-11-08 |
2012-05-23 |
Msd株式会社 |
新規縮環イミダゾール誘導体
|
US20060178367A1
(en)
|
2004-11-10 |
2006-08-10 |
Currie Kevin S |
Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
|
US20080207634A1
(en)
|
2004-12-17 |
2008-08-28 |
Kristjan Gudmundsson |
Chemical Compounds
|
JPWO2006070943A1
(ja)
|
2004-12-28 |
2008-06-12 |
武田薬品工業株式会社 |
縮合イミダゾール化合物およびその用途
|
CA2599987A1
(fr)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Composes heterocycliques liquefies et leur utilisation comme modulateurs de sirtuine
|
AU2006227300B2
(en)
|
2005-03-21 |
2012-02-02 |
Eli Lilly And Company |
Imidazopyridazine compounds
|
US7666880B2
(en)
|
2005-03-21 |
2010-02-23 |
S*Bio Pte Ltd. |
Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
|
WO2006100119A1
(fr)
|
2005-03-24 |
2006-09-28 |
Glaxo Group Limited |
Dérivés d’imidazo(1,2-a)pyridine utilisés en tant que médicament pour le traitement de maladie gastro-intestinales
|
WO2006107784A1
(fr)
|
2005-04-05 |
2006-10-12 |
Eli Lilly And Company |
Composes d’imidazopyridazine
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
GB0513423D0
(en)
|
2005-06-30 |
2005-08-03 |
Glaxo Group Ltd |
Novel compounds
|
JP2009501172A
(ja)
|
2005-07-11 |
2009-01-15 |
ノバルティス アクチエンゲゼルシャフト |
インドリルマレイミド誘導体
|
EP1910369A1
(fr)
|
2005-07-29 |
2008-04-16 |
Astellas Pharma Inc. |
Hétérocycles fusionnés en tant qu inhibiteurs de lck
|
WO2007025043A2
(fr)
|
2005-08-23 |
2007-03-01 |
Idenix Pharmaceuticals, Inc. |
Nucleosides cycliques a sept chainons
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
JP2009507032A
(ja)
|
2005-09-02 |
2009-02-19 |
アボット・ラボラトリーズ |
新規なイミダゾ系複素環
|
US20070078136A1
(en)
|
2005-09-22 |
2007-04-05 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
KR101121292B1
(ko)
|
2005-09-27 |
2012-04-13 |
에프. 호프만-라 로슈 아게 |
Mglur2 길항제로서 옥사다이아졸일 피라졸로-피리미딘
|
WO2007036732A1
(fr)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo[1,2-a]pyridine à activité anti-prolifération cellulaire
|
JO2769B1
(en)
|
2005-10-26 |
2014-03-15 |
جانسين فارماسوتيكا ان. في |
Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
|
JP2009515882A
(ja)
|
2005-11-10 |
2009-04-16 |
シェーリング コーポレイション |
プロテインキナーゼを阻害するための方法
|
JP5031760B2
(ja)
|
2005-11-10 |
2012-09-26 |
シェーリング コーポレイション |
プロテインキナーゼインヒビターとしてのイミダゾピラジン
|
US7718657B2
(en)
|
2005-12-16 |
2010-05-18 |
Cytokinetics, Inc. |
Certain indanyl urea modulators of the cardiac sarcomere
|
WO2007087283A2
(fr)
|
2006-01-23 |
2007-08-02 |
Vertex Pharmaceuticals Incorporated |
Thiophene-carboxamides utiles en tant qu'inhibiteurs de proteines kinases
|
JP2009524689A
(ja)
|
2006-01-25 |
2009-07-02 |
スミスクライン ビーチャム コーポレーション |
化合物
|
JP2009528388A
(ja)
|
2006-03-02 |
2009-08-06 |
スミスクライン・ビーチャム・コーポレイション |
Pi3キナーゼ阻害物質として用いられるチアゾロン
|
US20090175852A1
(en)
|
2006-06-06 |
2009-07-09 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
CA2654202A1
(fr)
|
2006-06-06 |
2007-12-21 |
Schering Corporation |
Imidazopyrazines utilisees en tant qu'inhibiteur de proteine kinase
|
ITVA20060041A1
(it)
|
2006-07-05 |
2008-01-06 |
Dialectica Srl |
Uso di composti derivati amminotiazolici, di loro composizioni farmaceutiche, nel trattamento di malattie caratterizzate dalla anormale repressione della trascrizione genica, particolarmente il morbo di huntington
|
EP2044061A2
(fr)
|
2006-07-20 |
2009-04-08 |
Mehmet Kahraman |
Inhibiteurs de la rho kinase à base de benzothiophène
|
WO2008014219A2
(fr)
|
2006-07-24 |
2008-01-31 |
Smithkline Beecham Corporation |
Dérivés de thiozolidinedione utilisés en tant qu'inhibiteurs de la p13-kinase
|
WO2008027812A2
(fr)
|
2006-08-28 |
2008-03-06 |
Forest Laboratories Holdings Limited |
Dérivés d'imidazopyridine et d'imidazopyrimidine
|
US20100144743A1
(en)
|
2006-09-05 |
2010-06-10 |
Board Of Regents, The University Of Texas System |
Compositions and methods for inhibition of tyrosine kinases
|
EP2063882A4
(fr)
|
2006-09-05 |
2010-03-03 |
Univ Emory |
Inhibiteurs de kinase pour la prévention ou le traitement d'une infection
|
AU2007292924A1
(en)
|
2006-09-07 |
2008-03-13 |
Biogen Idec Ma Inc. |
IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
|
MX2009003650A
(es)
|
2006-10-06 |
2009-04-22 |
Abbott Lab |
Nuevos imidazotiazoles e imidazoxazoles.
|
WO2008053285A1
(fr)
|
2006-10-30 |
2008-05-08 |
Draximage Limited |
Procédés de préparation de 2-méthoxyisobutylisonitrile et tétrafluoroborate de tétrakis(2-méthoxyisobutylisonitrile)cuivre(i)
|
WO2008057402A2
(fr)
|
2006-11-02 |
2008-05-15 |
Cytovia, Inc. |
N-aryl-isoxazolopyrimidin-4-amines et composés associés servant d'activateurs de caspases et d'inducteurs d'apoptose et leur utilisation
|
WO2008057512A2
(fr)
|
2006-11-08 |
2008-05-15 |
Schering Corporation |
Imidazopyrazines comme inhibiteurs de protéines kinases
|
CA2670042A1
(fr)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Inhibiteurs de metalloprotease a matrice heterobicyclique
|
US7622584B2
(en)
|
2006-11-24 |
2009-11-24 |
Samsung Mobile Display Co., Ltd. |
Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound
|
CA2670870A1
(fr)
|
2006-12-04 |
2008-06-12 |
Astrazeneca Ab |
Composes d'uree polycycliques antibacteriens
|
US7977336B2
(en)
|
2006-12-28 |
2011-07-12 |
Banyu Pharmaceutical Co. Ltd |
Aminopyrimidine derivatives as PLK1 inhibitors
|
AU2008205642B2
(en)
|
2007-01-12 |
2013-06-06 |
Msd K.K. |
Spirochromanon derivatives
|
US20080242862A1
(en)
|
2007-03-27 |
2008-10-02 |
Calderwood David J |
Novel imidazo based heterocycles
|
CN101679422A
(zh)
|
2007-03-28 |
2010-03-24 |
阵列生物制药公司 |
作为受体酪氨酸激酶抑制剂的咪唑并[1,2-a]吡啶化合物
|
UA101611C2
(ru)
|
2007-04-03 |
2013-04-25 |
Аррей Байофарма Инк. |
СОЕДИНЕНИЯ ИМИДАЗО[1,2-а]ПИРИДИНА КАК ИНГИБИТОРЫ ТИРОЗИНКИНАЗЫ РЕЦЕПТОРОВ
|
MX2009010523A
(es)
|
2007-04-10 |
2009-12-15 |
Lundbeck & Co As H |
Análogos de amidas heteroarílicas como antagonistas de p2x7.
|
WO2008133192A1
(fr)
|
2007-04-19 |
2008-11-06 |
Takeda Pharmaceutical Company Limited |
Composé d'imidazole fusionné et son utilisation
|
WO2008134553A1
(fr)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Procédés de traitement de maladies associées aux canaux sodiques au moyen de composés bicycliques
|
MX2009012066A
(es)
|
2007-05-09 |
2009-11-19 |
Novartis Ag |
Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
|
ES2393038T3
(es)
|
2007-05-10 |
2012-12-18 |
Biocryst Pharmaceuticals, Inc. |
Compuestos de tretrahidrofuro[3,4-D]dioxolano para su utlilización en el tratamiento de las infecciones víricas y del cáncer
|
US20100216779A1
(en)
|
2007-06-01 |
2010-08-26 |
Glaxosmithkline Llc |
Imidazopyridine Kinase Inhibitors
|
CA2690557A1
(fr)
|
2007-06-14 |
2008-12-24 |
Schering Corporation |
Imidazopyrazines comme inhibiteurs de la proteine kinase
|
KR101030007B1
(ko)
|
2007-06-15 |
2011-04-20 |
삼성모바일디스플레이주식회사 |
헤테로방향환 함유 화합물, 이의 제조 방법 및 이를 이용한유기 발광 소자
|
CA2690192A1
(fr)
|
2007-06-26 |
2008-12-31 |
Gilead Colorado, Inc. |
Inhibiteurs d'imidazopyridinyl-thiazolyl-histone desacetylase
|
WO2009005675A1
(fr)
*
|
2007-06-28 |
2009-01-08 |
Abbott Laboratories |
Nouvelles triazolopyridazines
|
FR2918061B1
(fr)
|
2007-06-28 |
2010-10-22 |
Sanofi Aventis |
Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
|
FR2918986B1
(fr)
|
2007-07-19 |
2009-09-04 |
Sanofi Aventis Sa |
Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
|
CA2693817A1
(fr)
|
2007-07-27 |
2009-02-05 |
Actelion Pharmaceuticals Ltd |
Derives de trans-3-aza-bicyclo[3.1.0]hexane
|
MX2010001340A
(es)
|
2007-07-31 |
2010-06-02 |
Schering Corp |
Combianacion de agente antimitotico e inhibidor de aurora quinasa como tratamiento anticancerigeno.
|
BRPI0814939A2
(pt)
|
2007-08-10 |
2015-01-27 |
Glaxosmithkline Llc |
Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero.
|
KR20100049589A
(ko)
|
2007-08-14 |
2010-05-12 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
암 치료를 위한 융합된 이미다졸
|
WO2009023253A2
(fr)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
Dérivés d'imidazo[l,2-α]pyridine utilisés comme modulateurs du récepteur sérotoninergique 5-ht2a dans le traitement des troubles qui lui sont associés
|
GB0716292D0
(en)
|
2007-08-21 |
2007-09-26 |
Biofocus Dpi Ltd |
Imidazopyrazine compounds
|
US20110046127A1
(en)
|
2007-11-08 |
2011-02-24 |
Paolo Pevarello |
Imidazopyridazines for Use as Protein Kinase Inhibitors
|
CA2704645A1
(fr)
|
2007-11-09 |
2009-05-14 |
The Salk Institute For Biological Studies |
Inhibiteurs non nucleosidiques de la transcriptase inverse
|
KR20100110804A
(ko)
*
|
2007-11-30 |
2010-10-13 |
와이어쓰 엘엘씨 |
포스포디에스테라제 10의 저해물질로서의 아릴 및 헤테로아릴 융합된 이미다조[1,5-a]피라진
|
CN101952283B
(zh)
|
2007-12-14 |
2013-04-17 |
霍夫曼-拉罗奇有限公司 |
咪唑并[1,2-a]吡啶和咪唑并[1,2-b]哒嗪衍生物
|
JP2011507900A
(ja)
|
2007-12-21 |
2011-03-10 |
ワイス・エルエルシー |
イミダゾ[1,2−a]ピリジン化合物
|
JP2011507902A
(ja)
|
2007-12-21 |
2011-03-10 |
ワイス・エルエルシー |
肝臓X受容体のモジュレーターとしてのイミダゾ[1,2−b]ピリダジン化合物
|
KR101428840B1
(ko)
|
2007-12-21 |
2014-08-08 |
이데미쓰 고산 가부시키가이샤 |
유기 전계 발광 소자
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
WO2009097233A1
(fr)
|
2008-01-28 |
2009-08-06 |
Schering Corporation |
Imidazopyrazines comme inhibiteurs de protéines kinases
|
WO2009108546A1
(fr)
|
2008-02-26 |
2009-09-03 |
Merck & Co., Inc. |
Inhibiteurs de l'ahcy hydrolase destinés au traitement de l'hyper-homocystéinémie
|
EP2288611B1
(fr)
|
2008-03-20 |
2013-05-15 |
Amgen Inc. |
Modulateurs d aurora kinase et procédé d utilisation
|
DE102008017853A1
(de)
|
2008-04-09 |
2009-10-15 |
Merck Patent Gmbh |
Thienopyrimidine
|
JP5637982B2
(ja)
|
2008-04-09 |
2014-12-10 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
脂肪酸アミド加水分解酵素の阻害剤
|
EA020659B1
(ru)
|
2008-04-23 |
2014-12-30 |
Джилид Сайэнс, Инк. |
1'-замещённые карбануклеозидные аналоги для противовирусной терапии
|
WO2010036407A2
(fr)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Analogues nucléosidiques antiviraux
|
CA2724842A1
(fr)
|
2008-05-19 |
2009-11-26 |
Sunovion Pharmaceuticals Inc. |
Composes imidazo[1,2-a]pyridines
|
AU2009251324A1
(en)
|
2008-05-29 |
2009-12-03 |
Sirtris Pharmaceuticals, Inc. |
Imidazopyridine and related analogs as sirtuin modulators
|
AR072008A1
(es)
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
EP2306836B1
(fr)
|
2008-07-01 |
2016-09-07 |
PTC Therapeutics, Inc. |
Modulateurs de l'expression de la protéine bmi-1
|
EP2303881A2
(fr)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Composés inhibiteurs hétérocycliques condensés d'histone déacétylase et/ou de kinases cycline-dépendantes
|
US8476430B2
(en)
|
2008-07-24 |
2013-07-02 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
WO2010016005A1
(fr)
|
2008-08-06 |
2010-02-11 |
Pfizer Inc. |
Composés 2-hétérocyclylamino pyrazines substituées en position 6 en tant qu'inhibiteurs de chk-1
|
FR2934994B1
(fr)
|
2008-08-12 |
2010-09-17 |
Sanofi Aventis |
Derives de 2-alkyl-6cycloamino-3-(pyridin-4-yl)imidaz°1,2-b! pyridazine, leur preparation et leur application en therapeutique
|
US8198449B2
(en)
|
2008-09-11 |
2012-06-12 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
WO2010033906A2
(fr)
|
2008-09-19 |
2010-03-25 |
President And Fellows Of Harvard College |
Induction efficace de cellules souches pluripotentes au moyen de composés à petite molécule
|
WO2010048149A2
(fr)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Modulateurs hétérocycliques de gpr119 pour le traitement d'une maladie
|
JP5416944B2
(ja)
|
2008-10-23 |
2014-02-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
WO2010054253A1
(fr)
|
2008-11-07 |
2010-05-14 |
Biotie Therapies Gmbh |
Dérivés de triazine en tant qu’inhibiteurs de phosphodiestérases
|
WO2010059838A2
(fr)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Inhibiteurs de pde4 sélectifs pour la forme longue de pde4 pour traiter une inflammation et éviter des effets secondaires
|
WO2010059836A1
(fr)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Composés bicycliques substitués à pont aza pour maladie cardiovasculaire et du système nerveux central
|
GB0822981D0
(en)
|
2008-12-17 |
2009-01-21 |
Summit Corp Plc |
Compounds for treatment of duchenne muscular dystrophy
|
JP2012512255A
(ja)
|
2008-12-17 |
2012-05-31 |
アムジエン・インコーポレーテツド |
ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物
|
JP5210187B2
(ja)
|
2009-01-22 |
2013-06-12 |
ユー・ディー・シー アイルランド リミテッド |
有機電界発光素子
|
EP2210891A1
(fr)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
Nouveaux ligands du récepteur de l'adénosine et leurs utilisations
|
WO2010088518A2
(fr)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Modulateurs hétérocycliques du gpr119 pour le traitement de maladies
|
WO2010097367A1
(fr)
|
2009-02-24 |
2010-09-02 |
Janssen Pharmaceutica Nv |
Ligands radiomarqués de pde10
|
US8367222B2
(en)
|
2009-02-27 |
2013-02-05 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescent device
|
PL2404922T3
(pl)
|
2009-03-05 |
2017-03-31 |
Astellas Pharma Inc. |
Związki chinoksalinowe
|
MX2011009796A
(es)
|
2009-03-20 |
2011-12-14 |
Amgen Inc |
Inhibidores de la cinasa pi3.
|
WO2010110277A1
(fr)
|
2009-03-24 |
2010-09-30 |
出光興産株式会社 |
Elément électroluminescent organique
|
KR101792837B1
(ko)
|
2009-04-16 |
2017-11-02 |
푼다시온 센트로 나시오날 드 인베스티가시오네스 온콜로기카스 카를로스Ⅲ |
키나아제 억제제로서 사용을 위한 이미다조피라진
|
TW201111383A
(en)
*
|
2009-05-29 |
2011-04-01 |
Wyeth Llc |
Substituted imidazo[1,5-a]quinoxalines as inhibitors of phosphodiesterase 10
|
EP2456440B1
(fr)
*
|
2009-07-22 |
2015-08-19 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de quinoléinone pde2
|
TW201107329A
(en)
|
2009-07-30 |
2011-03-01 |
Oncotherapy Science Inc |
Fused imidazole derivative having ttk inhibitory action
|
KR101551526B1
(ko)
|
2009-08-19 |
2015-09-08 |
이데미쓰 고산 가부시키가이샤 |
방향족 아민 유도체 및 그것을 이용한 유기 전기발광 소자
|
EA019673B1
(ru)
|
2009-10-30 |
2014-05-30 |
Янссен Фармацевтика Нв |
Радиоактивно меченные pde10 лиганды
|
US20120220581A1
(en)
|
2009-10-30 |
2012-08-30 |
Janssen-Cilag, S.A. |
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
|
US9278926B2
(en)
|
2009-11-16 |
2016-03-08 |
Idemitsu Kosan Co., Ltd. |
Aromatic amine derivative, and organic electroluminescent element comprising same
|
ES2627703T3
(es)
|
2010-01-22 |
2017-07-31 |
Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii |
Inhibidores de PI3·quinasa
|
AR080754A1
(es)
*
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
US9540379B2
(en)
|
2011-01-31 |
2017-01-10 |
Boehringer Ingelheim International Gmbh |
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
|
WO2013000924A1
(fr)
|
2011-06-27 |
2013-01-03 |
Janssen Pharmaceutica Nv |
Dérivés de 1-aryl-4-méthyl-[1,2,4]triazolo[4,3-a]quinoxaline
|
WO2013034755A1
(fr)
|
2011-09-09 |
2013-03-14 |
H. Lundbeck A/S |
Dérivés de triazolopyrazine et leur utilisation pour le traitement de troubles neurologiques et psychiatriques
|
WO2013034761A1
(fr)
|
2011-09-09 |
2013-03-14 |
H. Lundbeck A/S |
Composés de pyridine et leurs utilisations
|
JP6174695B2
(ja)
|
2012-07-09 |
2017-08-02 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ホスホジエステラーゼ10酵素の阻害剤
|